Acetyl-L-Carnitine — Frequently Asked Questions
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Frequently Asked Questions
ALCAR vs L-Carnitine — what is the difference?
ALCAR vs L-Carnitine — what is the difference?
ALCAR (acetyl-L-carnitine) has an acetyl group attached that allows it to cross the blood-brain barrier efficiently, making it effective for cognitive benefits. Regular L-carnitine does not cross the BBB well and is primarily used for fat metabolism and exercise performance. For brain health, ALCAR is the correct choice. For fitness goals, L-carnitine L-tartrate (LCLT) may be preferred.
Can ALCAR help with depression?
Can ALCAR help with depression?
Yes. A 2018 meta-analysis of 12 RCTs (Veronese et al.) found ALCAR was as effective as standard antidepressants for reducing depressive symptoms, with significantly fewer side effects. Typical antidepressant doses in trials were 1000-3000mg/day. ALCAR is not a replacement for prescribed antidepressants but may be a useful adjunct or alternative under medical supervision.
Is the TMAO concern real for ALCAR?
Is the TMAO concern real for ALCAR?
Some L-carnitine is converted to TMAO by gut bacteria, and elevated TMAO has been associated with cardiovascular risk in observational studies. However, this concern is more relevant to high-dose, long-term L-carnitine use. ALCAR at standard nootropic doses (500-1500mg) has not been shown to significantly elevate TMAO. The cardiovascular risk from TMAO remains debated in the scientific community.
References
- Montgomery SA, Thal LJ, Amrein R (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology. DOI PubMed
- Veronese N, Stubbs B, Solmi M, et al. (2018). Acetyl-L-Carnitine supplementation and the treatment of depressive symptoms: a systematic review and meta-analysis. Psychosomatic Medicine. DOI PubMed
- Ames BN, Liu J (2004). Delaying the mitochondrial decay of aging with acetylcarnitine. Annals of the New York Academy of Sciences. DOI PubMed